Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-790
Closed -$1.82K – 1070
2020
Q1
$1.82K Hold
790
– – ﹤0.01% 925
2019
Q4
$3.68K Hold
790
– – ﹤0.01% 925
2019
Q3
$3.65K Hold
790
– – ﹤0.01% 924
2019
Q2
$3.69K Hold
790
– – ﹤0.01% 944
2019
Q1
$3.4K Hold
790
– – ﹤0.01% 959
2018
Q4
$3.1K Hold
790
– – ﹤0.01% 964
2018
Q3
$3.61K Hold
790
– – ﹤0.01% 993
2018
Q2
$3.66K Hold
790
– – ﹤0.01% 1008
2018
Q1
$5.74K Hold
790
– – ﹤0.01% 926
2017
Q4
$5.1K Hold
790
– – ﹤0.01% 944
2017
Q3
$5.21K Buy
+790
New +$4.89K ﹤0.01% 945

Other funds holding ABEV

RBC Europe's ABEV Position: Q2 2020 in Review

RBC Europe sold out of Ambev (ABEV) in Q2 2020, closing a stake of 790 shares — an estimated $1.82K sold.

RBC Europe first reported a position in ABEV in Q3 2017 and held it in 11 quarters. The position peaked at $5.74K in Q1 2018. 272 funds tracked by Wall St. Rank hold ABEV as of Q2 2020.

  • RBC Europe reported no remaining Ambev position as of Q2 2020 after selling out during the quarter.
  • RBC Europe sold 790 Ambev shares in Q2 2020, an estimated $1.82K.
  • RBC Europe first reported a position in Ambev in Q3 2017 and held it in 11 quarters.
  • RBC Europe's Ambev position peaked at $5.74K in Q1 2018.
  • 272 funds tracked by Wall St. Rank held Ambev as of Q2 2020.

Based on RBC Europe's 13F filing for Q2 2020, filed 9 Nov 2023.